Donald J. Lehmann

2.1k total citations
26 papers, 1.3k citations indexed

About

Donald J. Lehmann is a scholar working on Physiology, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, Donald J. Lehmann has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 5 papers in Pharmacology and 4 papers in Cognitive Neuroscience. Recurrent topics in Donald J. Lehmann's work include Alzheimer's disease research and treatments (11 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Computational Drug Discovery Methods (4 papers). Donald J. Lehmann is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Computational Drug Discovery Methods (4 papers). Donald J. Lehmann collaborates with scholars based in United Kingdom, Spain and Germany. Donald J. Lehmann's co-authors include A. David Smith, Mario Cortina‐Borja, Donald Warden, Carole Johnston, Onofre Combarros, Inge Strauch, Alexander A. Borbély, James McBroom, Eef Hogervorst and Patrick G. Kehoe and has published in prestigious journals such as American Journal of Epidemiology, Neuroscience and Human Molecular Genetics.

In The Last Decade

Donald J. Lehmann

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald J. Lehmann United Kingdom 18 382 248 237 237 195 26 1.3k
Giuseppe Gambina Italy 22 483 1.3× 232 0.9× 259 1.1× 172 0.7× 134 0.7× 50 1.3k
Eugene Lin Taiwan 28 213 0.6× 734 3.0× 159 0.7× 200 0.8× 387 2.0× 85 2.1k
Karen Sundell United States 20 534 1.4× 370 1.5× 371 1.6× 83 0.4× 59 0.3× 40 1.4k
Christine A. Szekely United States 17 1.3k 3.3× 346 1.4× 326 1.4× 344 1.5× 105 0.5× 25 2.5k
Katsuya Urakami Japan 30 1.4k 3.5× 702 2.8× 270 1.1× 156 0.7× 236 1.2× 116 3.0k
D Bouthillier Canada 13 713 1.9× 393 1.6× 137 0.6× 72 0.3× 148 0.8× 25 1.6k
G. W. Small United States 7 1.2k 3.0× 548 2.2× 216 0.9× 108 0.5× 208 1.1× 9 1.8k
Alette M. Wessels United States 19 1.0k 2.6× 269 1.1× 319 1.3× 200 0.8× 59 0.3× 49 1.9k
Eve H. Pickering United States 21 749 2.0× 601 2.4× 130 0.5× 82 0.3× 164 0.8× 29 1.6k
Robert T. Dunn United States 26 105 0.3× 453 1.8× 239 1.0× 607 2.6× 114 0.6× 45 2.7k

Countries citing papers authored by Donald J. Lehmann

Since Specialization
Citations

This map shows the geographic impact of Donald J. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald J. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald J. Lehmann more than expected).

Fields of papers citing papers by Donald J. Lehmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald J. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald J. Lehmann. The network helps show where Donald J. Lehmann may publish in the future.

Co-authorship network of co-authors of Donald J. Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Donald J. Lehmann. A scholar is included among the top collaborators of Donald J. Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald J. Lehmann. Donald J. Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belbin, Olivia, Kevin Morgan, Donald Warden, et al.. (2019). The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer’s Disease Risk. Journal of Alzheimer s Disease. 68(4). 1535–1547. 9 indexed citations
2.
3.
Moore, Hannah C., Donald J. Lehmann, Nicholas de Klerk, et al.. (2013). How Accurate Are International Classification of Diseases-10 Diagnosis Codes in Detecting Influenza and Pertussis Hospitalizations in Children?. Journal of the Pediatric Infectious Diseases Society. 3(3). 255–260. 40 indexed citations
4.
Lehmann, Donald J. & Holger Theisel. (2011). Features in Continuous Parallel Coordinates. IEEE Transactions on Visualization and Computer Graphics. 17(12). 1912–1921. 10 indexed citations
5.
Lehmann, Donald J., Helga Refsum, Donald Warden, et al.. (2011). The vitamin D receptor gene is associated with Alzheimer's disease. Neuroscience Letters. 504(2). 79–82. 73 indexed citations
6.
Cortina‐Borja, Mario, A. David Smith, Onofre Combarros, & Donald J. Lehmann. (2009). The synergy factor: a statistic to measure interactions in complex diseases. BMC Research Notes. 2(1). 105–105. 91 indexed citations
7.
Quiroga, I, Donald J. Lehmann, Martin Barnardo, et al.. (2009). Association study of MICA and MICB in Alzheimer’s disease. Tissue Antigens. 74(3). 241–243. 2 indexed citations
8.
Butler, Helen, Donald Warden, Eef Hogervorst, et al.. (2009). Association of the aromatase gene with Alzheimer's disease in women. Neuroscience Letters. 468(3). 202–206. 36 indexed citations
9.
Combarros, Onofre, Mario Cortina‐Borja, A. David Smith, & Donald J. Lehmann. (2008). Epistasis in sporadic Alzheimer's disease. Neurobiology of Aging. 30(9). 1333–1349. 91 indexed citations
10.
Belbin, Olivia, J L Dunn, Sally Chappell, et al.. (2007). A SNP in the ACT gene associated with astrocytosis and rapid cognitive decline in AD. Neurobiology of Aging. 29(8). 1167–1176. 11 indexed citations
11.
Lehmann, Donald J., Martin Barnardo, Susan V. Fuggle, et al.. (2006). Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity?. Journal of Neuroinflammation. 3(1). 33–33. 15 indexed citations
12.
Lehmann, Donald J.. (2006). Apolipoprotein E  4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study. Journal of Neurology Neurosurgery & Psychiatry. 77(8). 902–908. 39 indexed citations
13.
Lehmann, Donald J., Mario Cortina‐Borja, Donald Warden, et al.. (2005). Large Meta-Analysis Establishes the ACE Insertion-Deletion Polymorphism as a Marker of Alzheimer's Disease. American Journal of Epidemiology. 162(4). 305–317. 162 indexed citations
14.
Tsuno, Norifumi, et al.. (2004). Fluctuations of Source Locations of EEG Activity during Transition from Alertness to Sleep in Alzheimer’s Disease and Vascular Dementia. Neuropsychobiology. 50(3). 267–272. 15 indexed citations
15.
Hogervorst, Eef, Donald J. Lehmann, Donald Warden, James McBroom, & A. David Smith. (2002). Apolipoprotein E ε4 and testosterone interact in the risk of Alzheimer's disease in men. International Journal of Geriatric Psychiatry. 17(10). 938–940. 62 indexed citations
16.
Lehmann, Donald J.. (2001). HLA class I, II & III genes in confirmed late-onset Alzheimer's disease. Neurobiology of Aging. 22(1). 71–77. 24 indexed citations
17.
Lehmann, Donald J., Zsuzsanna Nagy, S. Litchfield, Mario Cortina‐Borja, & A. David Smith. (2000). Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease. Human Genetics. 106(4). 447–452. 44 indexed citations
18.
Lehmann, Donald J., Carole Johnston, & A. David Smith. (1997). Synergy Between the Genes for Butyrylcholinesterase K Variant and Apolipoprotein E4 in Late-Onset Confirmed Alzheimer's Disease. Human Molecular Genetics. 6(11). 1933–1936. 164 indexed citations
19.
Borbély, Alexander A., et al.. (1985). Effect of benzodiazepine hypnotics on all-night sleep EEG spectra.. PubMed. 4(3). 189–94. 195 indexed citations
20.
Schmidlin, D., et al.. (1982). Day-time residual effects and motor activity after three benzodiazepine hypnotics.. PubMed. 32(4). 461–5. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Gambina Breakdown of academic impact, for papers by Eugene Lin Breakdown of academic impact, for papers by Karen Sundell Breakdown of academic impact, for papers by Christine A. Szekely Breakdown of academic impact, for papers by Katsuya Urakami Breakdown of academic impact, for papers by D Bouthillier Breakdown of academic impact, for papers by G. W. Small Breakdown of academic impact, for papers by Alette M. Wessels Breakdown of academic impact, for papers by Eve H. Pickering Breakdown of academic impact, for papers by Robert T. Dunn
Rankless by CCL
2026